People, Supplier News

Avantor Hires Emmanuel Ligner as Its New President, CEO

The new Avantor chief exec was most recently CEO of Cerba HealthCare.

Author Image

By: Sam Brusco

Associate Editor

Emmanuel Ligner. Photo: LinkedIn.

Avantor, a provider of products and services to the life sciences and advanced technology industries, has named Emmanuel Ligner as its president and CEO effective August 18. Ligner succeeds Michael Stubblefield, who will step down as director, president, and CEO upon Ligner’s appointment.

Ligner touts more than three decades of experience in the life sciences industry. During his 12 years at GE Life Sciences, he held several global leadership roles, culminating in his appointment as president and CEO.

After GE Life Sciences’ biopharma business to Danaher, Ligner led the launch of Cytiva and spent four years building the business, including the integration of Pall Life Sciences. He began his career in Japan with Otsuka Pharmaceuticals before joining Abbott Japan.

Ligner was most recently CEO of Cerba HealthCare.

“Emmanuel is a proven CEO and leader with extensive experience driving commercial growth and building high-performing, empowered teams at large-scale global life sciences organizations,” said Jonathan Peacock, Chairman of the Board of Directors. “The Board is confident Emmanuel is the right person to lead Avantor in its next chapter to deliver competitive growth and value in both Lab Solutions and Bioscience Production.”

“I have long admired Avantor as an industry leader with an attractive portfolio, global supply chain and diverse customer base,” said Ligner. “I believe this company has tremendous potential and I look forward to working closely with our Board, leadership team and the thousands of talented associates around the world to capitalize on market opportunities and create value for shareholders.”

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters